Systematic Review

Accepted on 10 Dec 2024

Network Meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis

in Gastrointestinal and Hepatic Pharmacology

Wenkai Zhang
Songbo Zhao
Jipin Li
Yihua Sun
Xiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481678

Systematic Review

Accepted on 09 Dec 2024

Administration of Anticoagulation Strategies for Portal Vein Thrombosis in Cirrhosis: Network Meta-Analysis

in Gastrointestinal and Hepatic Pharmacology

Hui-Jun Li
尹富强
Yu-Tong Ma
Teng-Yu Gao
Yu-Ting Tao
Xin Liu
Xianfeng Shen
Chao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1462338

Original Research

Published on 06 Dec 2024

Effect of Helicobacter pylori-related chronic gastritis on gastrointestinal microorganisms and brain neurotransmitters in mice

in Gastrointestinal and Hepatic Pharmacology

Hai-Hua Liu
Tang-Tang Lin
Qi-Jia Zhang
Ling Zhang
Jin-Ying Fang
Ling Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472437

232 views

Editorial

Published on 04 Dec 2024

Editorial: The roles of pathogens in gut-related diseases and the strategies for inhibiting their growth

in Gastrointestinal and Hepatic Pharmacology

Imran Khan
Huang Gouxin
Shafia Khan
Abid Ali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513694

308 views

Original Research

Published on 02 Dec 2024

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

in Gastrointestinal and Hepatic Pharmacology

Nevertyty Mohamed Mahmoud
Shimaa M. Elshazly
Fatma El-shaarawy
Sawsan A. Zaitone
Afaf A. Aldahish
Gehan A. Ahmed
Manal S. Fawzy
Sheka Yagub Aloyouni
Sally Y. Abed
Tahani Saeedi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491249

399 views

Review

Published on 28 Nov 2024

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

in Gastrointestinal and Hepatic Pharmacology

Xiao Hong
Shuo Huang
He Jiang
Qing Ma
Jiang Qiu
Qihan Luo
Chunlu Cao
Yiyang Xu
Fuzhe Chen
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432480

913 views

Original Research

Published on 25 Nov 2024

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

in Gastrointestinal and Hepatic Pharmacology

Zhiyuan Zhang
Yifan Yao
Li Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500810

442 views

Original Research

Published on 25 Nov 2024

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

in Gastrointestinal and Hepatic Pharmacology

Johnny Amer
Ahmad Salhab
Enas Hussini
Rasha Shweiki
Iman Zahran
Mohammad Far

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484278

511 views

Original Research

Published on 22 Nov 2024

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

in Gastrointestinal and Hepatic Pharmacology

Meng Liu
Yuhui Wang
Xiaotian Xu
Guoqiang Guan
Shu Zhang
Shengnan Zhu
Yang Liu
Yizhun Zhu
Xiaoqun Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448863

592 views

Original Research

Published on 21 Nov 2024

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

in Gastrointestinal and Hepatic Pharmacology

Li Song
Shuo Huang
Honghao Yan
Qing Ma
Qihan Luo
Jiang Qiu
Minxia Chen
Zongyuan Li
He Jiang
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423031

756 views

Original Research

Published on 20 Nov 2024

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

in Gastrointestinal and Hepatic Pharmacology

Tekleab Teka
Jiang Wu
Patrick Kwabena Oduro
Ze Li
Chenxi Wang
Hao Chen
Lin Zhang
Haitao Wang
Liming Wang
Lifeng Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485035

669 views

Original Research

Published on 13 Nov 2024

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

in Gastrointestinal and Hepatic Pharmacology

Andy Wai Kan Yeung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498464

404 views

Original Research

Published on 13 Nov 2024

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

in Gastrointestinal and Hepatic Pharmacology

Hui Guo
Qian Guo
Zhiqiang Li
Ze Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461398

1,218 views

Original Research

Published on 08 Nov 2024

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Szilvia B. László
Barbara Hutka
András S. Tóth
Tamás Hegyes
Zsuzsanna O. Demeter
Arezoo Haghighi
Gerda Wachtl
Ágnes Kelemen
Anna Jakab
Klára Gyires

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468579

512 views

Clinical Trial

Published on 08 Nov 2024

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

in Gastrointestinal and Hepatic Pharmacology

Eman Mohamed Elmokadem
Dina Khaled Abou El Fadl
Nermin Eissa
Najla Abdulaziz Alnassar
Ahmed M. Bassiouny
Amir Eskander Hanna Samy
Nouran Omar El Said

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413246

413 views

Original Research

Published on 07 Nov 2024

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis

in Gastrointestinal and Hepatic Pharmacology

Jing Xie
Xinhua Liang
Fangfang Xie
Canxin Huang
Zijun Lin
Shuping Xie
Fangying Yang
Fengfeng Zheng
Lanlan Geng
Wanfu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409001

581 views

Navigation group

Articles

Network Meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis

Administration of Anticoagulation Strategies for Portal Vein Thrombosis in Cirrhosis: Network Meta-Analysis

Effect of Helicobacter pylori-related chronic gastritis on gastrointestinal microorganisms and brain neurotransmitters in mice

Editorial: The roles of pathogens in gut-related diseases and the strategies for inhibiting their growth

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis